Latest news
ASCO 2026: Why oncology is also paying attention to GLP-1 medicines
Early signals around GLP-1s are pushing cancer policy to look beyond the tumour.
Colon Cancer MRD Testing Is Nearing the Access Threshold
Breast Cancer Blood Tests Could Bring Treatment Decisions Earlier
Lung Cancer Screening Now Has a Diagnostic Bottleneck
Liquid Biopsy Turns Precision Oncology Into an NHS Delivery Test
Molecular Testing Is Europe’s Real Precision Oncology Infrastructure
Cancer Approval Is No Longer Enough
Europe’s Cancer Inequality Map Becomes a Performance Test
Europe’s Cancer Projects Start Looking Like Delivery Infrastructure
EU Cancer Policy Moves Back Into Budget Politics
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.